$4,606.91
0.59% yesterday
Nasdaq, Mar 31, 10:06 pm CET
ISIN
US09857L1089
Symbol
BKNG

Booking Target price 2025 - Analyst rating & recommendation

Booking Classifications & Recommendation:

Buy
68%
Hold
32%

Booking Price Target

Target Price $5,707.34
Price $4,606.91
Potential 23.89%
Number of Estimates 35
35 Analysts have issued a price target Booking 2026 . The average Booking target price is $5,707.34. This is 23.89% higher than the current stock price. The highest price target is $6,500.00 41.09% , the lowest is $4,720.00 2.45% .
A rating was issued by 41 analysts: 28 Analysts recommend Booking to buy, 13 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Booking stock has an average upside potential 2026 of 23.89% . Most analysts recommend the Booking stock at Purchase.

Sales and Margin forecast 2025, 2026 to 2029


Dec '24 2025
Estimates
Revenue Billion $ 23.74 25.33
11.11% 6.71%
EBITDA Margin 35.13% 35.91%
15.39% 2.21%
Net Margin 23.97% 26.38%
32.37% 10.06%

34 Analysts have issued a sales forecast Booking 2025 . The average Booking sales estimate is $25.3b . This is 6.71% higher than the revenue of the last 12 months(TTM). The highest sales forecast is $25.9b 9.13% , the lowest is $24.9b 4.78% .

This results in the following potential growth metrics:

Revenue Estimates

2024 $23.7b 11.11%
2025 $25.3b 6.71%
2026 $27.5b 8.63%
2027 $30.2b 9.66%
2028 $32.4b 7.43%
2029 $34.7b 7.03%

34 Analysts have issued an Booking EBITDA forecast 2025. The average Booking EBITDA estimate is $9.1b . This is 9.58% higher than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is $9.4b 13.20% , the lowest is $8.9b 7.14% .

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2024 $8.3b 28.21%
2025 $9.1b 9.07%
2026 $10.2b 12.25%
2027 $11.6b 13.55%
2028 $12.8b 10.18%
2029 $14.2b 11.30%

EBITDA Margin

2024 35.13% 15.39%
2025 35.91% 2.21%
2026 37.10% 3.31%
2027 38.42% 3.56%
2028 39.40% 2.55%
2029 40.97% 3.98%

29 Booking Analysts have issued a net profit forecast 2025. The average Booking net profit estimate is $6.7b . This is 17.22% higher than the net profit for the last 12 months(TTM). The highest net profit forecast is $7.0b 23.01% , the lowest is $5.9b 3.62% .

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2024 $5.7b 47.07%
2025 $6.7b 17.45%
2026 $7.8b 17.31%
2027 $9.3b 19.04%
2028 $10.8b 15.28%
2029 $12.4b 15.50%

Net Margin

2024 23.97% 32.37%
2025 26.38% 10.06%
2026 28.49% 8.00%
2027 30.92% 8.53%
2028 33.18% 7.31%
2029 35.81% 7.93%

Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2029


Dec '24 2025
Estimates
Earnings Per Share $ 172.68 202.81
47.07% 17.45%
P/E 22.72
EV/Sales 6.01

29 Analysts have issued a Booking forecast for earnings per share. The average Booking EPS is $202.81 . This is 17.22% higher than earnings per share in the financial year 2024. The highest EPS forecast is $212.84 23.01% , the lowest is $179.28 3.62% .

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2024 $172.68 47.07%
2025 $202.81 17.45%
2026 $237.93 17.32%
2027 $283.22 19.04%
2028 $326.50 15.28%
2029 $377.10 15.50%

P/E ratio

Current 26.63 13.40%
2025 22.72 14.68%
2026 19.36 14.79%
2027 16.27 15.96%
2028 14.11 13.28%
2029 12.22 13.39%

Based on analysts' sales estimates for 2025, the Booking stock is valued at an EV/Sales of 6.01 and an P/S ratio of 5.97 .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 6.41 8.46%
2025 6.01 6.24%
2026 5.53 7.95%
2027 5.04 8.81%
2028 4.70 6.92%
2029 4.39 6.57%

P/S ratio

Current 6.37 9.75%
2025 5.97 6.29%
2026 5.49 7.95%
2027 5.01 8.81%
2028 4.66 6.92%
2029 4.36 6.57%

Current Booking Upgrades & Downgrades

Analyst Rating Action Date
Citizens Capital Markets
Market Outperform
Market Outperform
Unchanged Feb 24 2025
Benchmark
Buy
Buy
Unchanged Feb 21 2025
Cantor Fitzgerald
Neutral
Neutral
Unchanged Feb 21 2025
Wells Fargo
Equal-Weight
Equal-Weight
Unchanged Feb 21 2025
B. Riley Securities
Buy
Buy
Unchanged Feb 21 2025
Citigroup
Buy
Buy
Unchanged Feb 21 2025
Barclays
Overweight
Overweight
Unchanged Feb 21 2025
Analyst Rating Date
Unchanged
Citizens Capital Markets:
Market Outperform
Market Outperform
Feb 24 2025
Unchanged
Benchmark:
Buy
Buy
Feb 21 2025
Unchanged
Cantor Fitzgerald:
Neutral
Neutral
Feb 21 2025
Unchanged
Wells Fargo:
Equal-Weight
Equal-Weight
Feb 21 2025
Unchanged
B. Riley Securities:
Buy
Buy
Feb 21 2025
Unchanged
Citigroup:
Buy
Buy
Feb 21 2025
Unchanged
Barclays:
Overweight
Overweight
Feb 21 2025

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today